FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carla Mathias

Research Profile

Chemicals & Drugs

Anatomy

KB Cells

Concepts & Ideas

Tissue Distribution

Living Beings

Procedures

Co-author Network

Publications

TOP 3
Nathan E Basken; Carla J Mathias; Mark A Green
Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals.
Yui-May Hsiao; Carla J Mathias; Shiaw-Pyng Wey; Phillip E Fanwick; Mark A Green
Synthesis and biodistribution of lipophilic and monocationic gallium radiopharmaceuticals derived from N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine: potential agents for PET myocardial imaging with 68Ga.
Carla J Mathias; Mark A Green
A convenient route to [68Ga]Ga-MAA for use as a particulate PET perfusion tracer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carla Mathias (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Nathan E Basken; Carla J Mathias; Mark A Green
Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals.
Journal of pharmaceutical sciences 2009;98(6):2170-9.
2009: Yui-May Hsiao; Carla J Mathias; Shiaw-Pyng Wey; Phillip E Fanwick; Mark A Green
Synthesis and biodistribution of lipophilic and monocationic gallium radiopharmaceuticals derived from N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine: potential agents for PET myocardial imaging with 68Ga.
Nuclear medicine and biology 2009;36(1):39-45.
2008: Carla J Mathias; Mark A Green
A convenient route to [68Ga]Ga-MAA for use as a particulate PET perfusion tracer.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2008;66(12):1910-2.
2008: Nathan E Basken; Carla J Mathias; Alexander E Lipka; Mark A Green
Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins.
Nuclear medicine and biology 2008;35(3):281-6.
2007: Mark A Green; Carla J Mathias; Lynn R Willis; Rajash K Handa; Jeffrey L Lacy; Michael A Miller; Gary D Hutchins
Assessment of Cu-ETS as a PET radiopharmaceutical for evaluation of regional renal perfusion.
Nuclear medicine and biology 2007;34(3):247-55.
2005: Chun-Yen Ke; Carla J Mathias; Mark A Green
Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid.
Journal of the American Chemical Society 2005;127(20):7421-6.
2004: Chun-Yen Ke; Carla J Mathias; Mark A Green
Folate-receptor-targeted radionuclide imaging agents.
Advanced drug delivery reviews 2004;56(8):1143-60.
2003: Chun-Yen Ke; Carla J Mathias; Mark A Green
The folate receptor as a molecular target for tumor-selective radionuclide delivery.
Nuclear medicine and biology 2003;30(8):811-7.
2003: Carla J Mathias; Michael R Lewis; David E Reichert; Richard Laforest; Terry L Sharp; Jason S Lewis; Zhen Fan Yang; David J Waters; Paul W Snyder; Philip S Low; Michael J Welch; Mark A Green
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals.
Nuclear medicine and biology 2003;30(7):725-31.
2002: David P Trump; Carla J Mathias; Zhenfan Yang; Philip S Low; Mary Marmion; Mark A Green
Synthesis and evaluation of 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical.
Nuclear medicine and biology 2002;29(5):569-73.
2000: Carla J Mathias; D Hubers; Philip S Low; Mark A Green
Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical.
Bioconjugate chemistry 2000;11(2):253-7.
2000: NG Haynes; Jeffrey L Lacy; N Nayak; C S Martin; D Dai; Carla J Mathias; Mark A Green
Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(2):309-14.
1999: Carla J Mathias; S Wang; Philip S Low; David J Waters; Mark A Green
Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts.
Nuclear medicine and biology 1999;26(1):23-5.
1998: Carla J Mathias; S Wang; David J Waters; J J Turek; Philip S Low; Mark A Green
Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(9):1579-85.
1998: Carla J Mathias; Mark A Green
A kit formulation for preparation of [(111)In]In-DTPA-folate, a folate-receptor-targeted radiopharmaceutical.
Nuclear medicine and biology 1998;25(6):585-7.
1998: M Sri-Aran; Carla J Mathias; J K Lim; Mark A Green
Synthesis and evaluation of a monocationic copper(II) radiopharmaceutical derived from N-(2-pyridylmethyl)-N'-(salicylaldimino)-1,3-propanediamine.
Nuclear medicine and biology 1998;25(2):107-10.
1997: S Wang; J Luo; Douglas Lantrip; David J Waters; Carla J Mathias; Mark A Green; Philip L Fuchs; Philip S Low
Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical.
Bioconjugate chemistry 1997;8(5):673-9.
1997: J K Lim; Carla J Mathias; Mark A Green
Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions.
Journal of medicinal chemistry 1997;40(1):132-6.